Abstract
Carbonic anhydrase inhibitors (CAIs) are a class of pharmaceuticals used as antiglaucoma agents, diuretics, antiepileptics, in the management of mountain sickness, gastric and duodenal ulcers, neurological disorders or osteoporosis. We report here the inhibitory capacities of some phenolic compounds against three human CA isozymes (hCA I, hCA II, and hCA VI) and the gill carbonic anhydrase of the teleost fish Dicentrarchus labrax (European seabass) (dCA). The isozymes showed quite diverse inhibition profiles with these compounds. These data may lead to design novel CAIs with a diverse inhibition mechanism compared to sulfonamide/sulfamate inhibitors.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Bass / metabolism
-
Carbonic Anhydrase I / antagonists & inhibitors
-
Carbonic Anhydrase I / metabolism
-
Carbonic Anhydrase II / antagonists & inhibitors
-
Carbonic Anhydrase II / metabolism
-
Carbonic Anhydrase Inhibitors / chemistry*
-
Carbonic Anhydrase Inhibitors / pharmacology
-
Carbonic Anhydrases / chemistry*
-
Carbonic Anhydrases / metabolism
-
Fish Proteins / antagonists & inhibitors
-
Fish Proteins / metabolism
-
Humans
-
Isoenzymes / antagonists & inhibitors
-
Isoenzymes / metabolism
-
Phenols / chemistry*
-
Phenols / pharmacology
-
Sulfonamides / chemistry
-
Sulfonamides / pharmacology
-
Sulfonic Acids / chemistry
-
Sulfonic Acids / pharmacology
Substances
-
Carbonic Anhydrase Inhibitors
-
Fish Proteins
-
Isoenzymes
-
Phenols
-
Sulfonamides
-
Sulfonic Acids
-
sulfamic acid
-
Carbonic Anhydrase I
-
Carbonic Anhydrase II
-
Carbonic Anhydrases
-
carbonic anhydrase VI